Approval · Notice of Compliance 34011 · 2024
BOTOX: Notice of Compliance 34011
Issued September 11, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34011
- Date
- September 11, 2024
- Company
- AbbVie CorporationSaint-Laurent, Quebec, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Alternate drug substance manufacturing site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BOTOX; BOTOX COSMETIC | Not yet assigned | — |
Medicinal ingredients
- ONABOTULINUMTOXINA 50 UNIT per VIAL
- ONABOTULINUMTOXINA 100 UNIT per VIAL
- ONABOTULINUMTOXINA 200 UNIT per VIAL